On October 7, a compounding trade group filed a lawsuit challenging the agency's action, saying there was still a shortage of ...
Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, ...
The Food and Drug Administration (FDA) on Friday declared shortages of three intravenous drugs produced at a North Carolina ...
After securing FDA approval, they produce and sell these drugs to distributors ... would offer GPOs bonus payments from Medicare for taking steps to prevent drug shortages, such as signing ...
The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...
The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling medicines while it reevaluates its recent decision to declare the drugs back in ...
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...
Hurricane Helene damaged one of the major NC-based manufacturing facilities of IV fluids. What’s being done to help hospitals ...
A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...